Author

Jan Diekmann

BioNTech (Germany)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:multiome· 1 Organism:rat· 1

Frequent Co-Authors

Annette B. VogeliD· 1 shared Anuhar ChaturvediiD· 1 shared Charles L. DulbergeriD· 1 shared Janina Vogt· 1 shared Louis S. AtesiD· 1 shared Mustafa DikeniD· 1 shared Nataša VukoviciD· 1 shared Neha AgrawaliD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Annette B. VogelORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well-tolerated and efficacious in rodent models

Neha Agrawal, Louis S. Ates, Stefan A. Schille, Anuhar Chaturvedi, Janina Vogt, Nataša Vukovic, Charles L. Dulberger, Annette B. Vogel, Jan Diekmann, Mustafa Diken, Uğur Şahin

This paper describes two mRNA vaccines for tuberculosis that are immunogenic, well-tolerated, and effective in rodent models, entering clinical trials.

Nature Immunology · Jun 12, 2026Peer-reviewedImmunology